Global Anti Peptic Ulcer Drugs Market Size, Status, Research and Forecast 2019

Published On: Sep 2019

Format: PDF

Publisher: QY Research

Pages: 96

Report ID: 60444

In 2018, the global Anti Peptic Ulcer Drugs market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

This report focuses on the global Anti Peptic Ulcer Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Anti Peptic Ulcer Drugs development in United States, Europe and China.

The key players covered in this study
Eisai
Daewoong Pharmaceutical
Takeda Pharmaceutical
HeliCure
AstraZeneca
Ore Pharmaceuticals
Sihuan Pharmaceutical
GlaxoSmithKline
Pfizer
Abbott Laboratories
Yuhan Corporation
Cadila Healthcare
Boehringer Ingelheim

Market segment by Type, the product can be split into
Proton Pump Inhibitors (PPIs)
Potassium-Competitive Acid Blockers (P-CAB)
Antacids
H2 Antagonists
Antibiotics
Ulcer Protective Drugs

Market segment by Application, split into
Gastritis
Gastric Ulcers
Duodenal Ulcers
Gastroesophageal Reflux Disease (GERD)

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Anti Peptic Ulcer Drugs status, future forecast, growth opportunity, key market and key players.
To present the Anti Peptic Ulcer Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Anti Peptic Ulcer Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Anti Peptic Ulcer Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Proton Pump Inhibitors (PPIs)
1.4.3 Potassium-Competitive Acid Blockers (P-CAB)
1.4.4 Antacids
1.4.5 H2 Antagonists
1.4.6 Antibiotics
1.4.7 Ulcer Protective Drugs
1.5 Market by Application
1.5.1 Global Anti Peptic Ulcer Drugs Market Share by Application (2014-2025)
1.5.2 Gastritis
1.5.3 Gastric Ulcers
1.5.4 Duodenal Ulcers
1.5.5 Gastroesophageal Reflux Disease (GERD)
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Anti Peptic Ulcer Drugs Market Size
2.2 Anti Peptic Ulcer Drugs Growth Trends by Regions
2.2.1 Anti Peptic Ulcer Drugs Market Size by Regions (2014-2025)
2.2.2 Anti Peptic Ulcer Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Anti Peptic Ulcer Drugs Market Size by Manufacturers
3.1.1 Global Anti Peptic Ulcer Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Anti Peptic Ulcer Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Anti Peptic Ulcer Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Anti Peptic Ulcer Drugs Key Players Head office and Area Served
3.3 Key Players Anti Peptic Ulcer Drugs Product/Solution/Service
3.4 Date of Enter into Anti Peptic Ulcer Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Anti Peptic Ulcer Drugs Market Size by Type (2014-2019)
4.2 Global Anti Peptic Ulcer Drugs Market Size by Application (2014-2019)

5 United States
5.1 United States Anti Peptic Ulcer Drugs Market Size (2014-2019)
5.2 Anti Peptic Ulcer Drugs Key Players in United States
5.3 United States Anti Peptic Ulcer Drugs Market Size by Type
5.4 United States Anti Peptic Ulcer Drugs Market Size by Application

6 Europe
6.1 Europe Anti Peptic Ulcer Drugs Market Size (2014-2019)
6.2 Anti Peptic Ulcer Drugs Key Players in Europe
6.3 Europe Anti Peptic Ulcer Drugs Market Size by Type
6.4 Europe Anti Peptic Ulcer Drugs Market Size by Application

7 China
7.1 China Anti Peptic Ulcer Drugs Market Size (2014-2019)
7.2 Anti Peptic Ulcer Drugs Key Players in China
7.3 China Anti Peptic Ulcer Drugs Market Size by Type
7.4 China Anti Peptic Ulcer Drugs Market Size by Application

8 Japan
8.1 Japan Anti Peptic Ulcer Drugs Market Size (2014-2019)
8.2 Anti Peptic Ulcer Drugs Key Players in Japan
8.3 Japan Anti Peptic Ulcer Drugs Market Size by Type
8.4 Japan Anti Peptic Ulcer Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Anti Peptic Ulcer Drugs Market Size (2014-2019)
9.2 Anti Peptic Ulcer Drugs Key Players in Southeast Asia
9.3 Southeast Asia Anti Peptic Ulcer Drugs Market Size by Type
9.4 Southeast Asia Anti Peptic Ulcer Drugs Market Size by Application

10 India
10.1 India Anti Peptic Ulcer Drugs Market Size (2014-2019)
10.2 Anti Peptic Ulcer Drugs Key Players in India
10.3 India Anti Peptic Ulcer Drugs Market Size by Type
10.4 India Anti Peptic Ulcer Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Anti Peptic Ulcer Drugs Market Size (2014-2019)
11.2 Anti Peptic Ulcer Drugs Key Players in Central & South America
11.3 Central & South America Anti Peptic Ulcer Drugs Market Size by Type
11.4 Central & South America Anti Peptic Ulcer Drugs Market Size by Application

12 International Players Profiles
12.1 Eisai
12.1.1 Eisai Company Details
12.1.2 Company Description and Business Overview
12.1.3 Anti Peptic Ulcer Drugs Introduction
12.1.4 Eisai Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)
12.1.5 Eisai Recent Development
12.2 Daewoong Pharmaceutical
12.2.1 Daewoong Pharmaceutical Company Details
12.2.2 Company Description and Business Overview
12.2.3 Anti Peptic Ulcer Drugs Introduction
12.2.4 Daewoong Pharmaceutical Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)
12.2.5 Daewoong Pharmaceutical Recent Development
12.3 Takeda Pharmaceutical
12.3.1 Takeda Pharmaceutical Company Details
12.3.2 Company Description and Business Overview
12.3.3 Anti Peptic Ulcer Drugs Introduction
12.3.4 Takeda Pharmaceutical Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)
12.3.5 Takeda Pharmaceutical Recent Development
12.4 HeliCure
12.4.1 HeliCure Company Details
12.4.2 Company Description and Business Overview
12.4.3 Anti Peptic Ulcer Drugs Introduction
12.4.4 HeliCure Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)
12.4.5 HeliCure Recent Development
12.5 AstraZeneca
12.5.1 AstraZeneca Company Details
12.5.2 Company Description and Business Overview
12.5.3 Anti Peptic Ulcer Drugs Introduction
12.5.4 AstraZeneca Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)
12.5.5 AstraZeneca Recent Development
12.6 Ore Pharmaceuticals
12.6.1 Ore Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Anti Peptic Ulcer Drugs Introduction
12.6.4 Ore Pharmaceuticals Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)
12.6.5 Ore Pharmaceuticals Recent Development
12.7 Sihuan Pharmaceutical
12.7.1 Sihuan Pharmaceutical Company Details
12.7.2 Company Description and Business Overview
12.7.3 Anti Peptic Ulcer Drugs Introduction
12.7.4 Sihuan Pharmaceutical Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)
12.7.5 Sihuan Pharmaceutical Recent Development
12.8 GlaxoSmithKline
12.8.1 GlaxoSmithKline Company Details
12.8.2 Company Description and Business Overview
12.8.3 Anti Peptic Ulcer Drugs Introduction
12.8.4 GlaxoSmithKline Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)
12.8.5 GlaxoSmithKline Recent Development
12.9 Pfizer
12.9.1 Pfizer Company Details
12.9.2 Company Description and Business Overview
12.9.3 Anti Peptic Ulcer Drugs Introduction
12.9.4 Pfizer Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)
12.9.5 Pfizer Recent Development
12.10 Abbott Laboratories
12.10.1 Abbott Laboratories Company Details
12.10.2 Company Description and Business Overview
12.10.3 Anti Peptic Ulcer Drugs Introduction
12.10.4 Abbott Laboratories Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)
12.10.5 Abbott Laboratories Recent Development
12.11 Yuhan Corporation
12.12 Cadila Healthcare
12.13 Boehringer Ingelheim

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details